Idiopathic pulmonary fibrosis: is it a familial disease?

被引:18
|
作者
Allam, J. Shirine
Limper, Andrew H.
机构
[1] Mayo Clin, Coll Med, Dept Internal Med, Div Pulm & Crit Care, Rochester, MN 55905 USA
[2] Mayo Clin, Coll Med, Thorac Dis Res Unit, Rochester, MN 55905 USA
关键词
familial interstitial pulmonary fibrosis; genetics; interstitial pulmonary fibrosis; surfactant proteins;
D O I
10.1097/01.mcp.0000239546.24831.61
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Purpose of review Idiopathic pulmonary fibrosis is a progressively fatal interstitial lung disease associated with pathological findings of usual interstitial, pneumonia. Its pathognesis is unknown, and there are no proven effective therapies Familial cases account for 0.5-2% of idiopathic pulmonary fibrosis. Familial idiopathic pulmonary fibrosis occurs as an autosomal dominant disorder with variable penetrance. The clinical characteristics of familial idiopathic pulmonary fibrosis are indistinguishable from sporadic idiopathic pulmonary fibrosis. These marked similarities support the hypothesis there may, in part, be a genetic basis for idiopathic pulmonary fibrosis. Recent findings Many investigations have evaluated genetic polymorphisms and idiopathic pulmonar fibrosis. Candidate genes include and surfactant protein genes. To date, no gene has been consistently identified to be-associated with idiopathic pulmonary fibrosis. Recent studies in familial, idiopathic pulmonary fibrosis have demonstrated a strong association with surfactant protein C gene mutations in one large kindred. Summary The pathogenesis of both idiopathic pulmonary fibrbsis and familial idiopathic pulmonary fibrosis remains unclear. A consistent genetic basis has not yet been demonstrated in all cases. Other factors, including variable gene expression, co-carriage of other modifying genes and environmental stimuli, particularly cigarette smoke, significantly contribute to disease expression.
引用
收藏
页码:312 / 317
页数:6
相关论文
共 50 条
  • [31] Early interstitial lung disease in familial pulmonary fibrosis
    Rosas, Ivan O.
    Ren, Ping
    Avila, Nilo A.
    Chow, Catherine K.
    Franks, Teri J.
    Travis, William D.
    McCoy, J. Philip, Jr.
    May, Rose M.
    Wu, Hai-Ping
    Nguyen, Dao M.
    Arcos-Burgos, Mauricio
    MacDonald, Sandra D.
    Gochuico, Bernadette R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 176 (07) : 698 - 705
  • [32] Familial Pulmonary Fibrosis: Natural History Of Preclinical Disease
    El-Chemaly, S.
    Ziegler, S. G.
    Wilson, K.
    Gahl, W. A.
    Moss, J.
    Gochuico, B. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [33] Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis
    Strykowski, Rachel
    Adegunsoye, Ayodeji
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2023, 43 (02) : 209 - 228
  • [34] FAMILIAL PULMONARY FIBROSIS
    MACMILLAN, JM
    DISEASES OF THE CHEST, 1951, 20 (04): : 426 - 436
  • [35] Familial Pulmonary Fibrosis
    Manali, Effrosyni D.
    Kolilekas, Likurgos
    Kannengiesser, Caroline
    Borie, Raphael
    Giouleka, Paschalina
    Tomos, Ioannis
    Kagouridis, Konstantinos
    Karakatsani, Anna
    Bouros, Demosthenes
    Crestani, Bruno
    Papiris, Spyros A.
    PNEUMON, 2016, 29 (02) : 114 - 119
  • [36] Risk factors for disease progression in idiopathic pulmonary fibrosis
    Raghu, Ganesh
    Ley, Brett
    Brown, Kevin K.
    Cottin, Vincent
    Gibson, Kevin F.
    Kaner, Robert J.
    Lederer, David J.
    Noble, Paul W.
    Song, Jin Woo
    Wells, Athol U.
    Whelan, Timothy P.
    Lynch, David A.
    Humphries, Stephen M.
    Moreau, Emmanuel
    Goodman, Krista
    Patterson, Scott D.
    Smith, Victoria
    Gong, Qi
    Sundy, John S.
    O'Riordan, Thomas G.
    Martinez, Fernando J.
    THORAX, 2020, 75 (01) : 78 - 80
  • [37] Comparison of disease progression subgroups in idiopathic pulmonary fibrosis
    Karkkainen, Miia
    Kettunen, Hannu-Pekka
    Nurmi, Hanna
    Selander, Tuomas
    Purokivi, Minna
    Kaarteenaho, Riitta
    BMC PULMONARY MEDICINE, 2019, 19 (01)
  • [38] Pirfenidone reduced disease progression in idiopathic pulmonary fibrosis
    Lake, Fiona
    ANNALS OF INTERNAL MEDICINE, 2014, 161 (08)
  • [39] Comparison of disease progression subgroups in idiopathic pulmonary fibrosis
    Miia Kärkkäinen
    Hannu-Pekka Kettunen
    Hanna Nurmi
    Tuomas Selander
    Minna Purokivi
    Riitta Kaarteenaho
    BMC Pulmonary Medicine, 19
  • [40] MOLECULAR BIOMARKERS IN IDIOPATHIC PULMONARY FIBROSIS AND DISEASE SEVERITY
    Crestani, B.
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2013, 30 : 27 - 32